Formulations

Lynparza comes in two formulations, tablets and capsules1,2

Lynparza tablets (150 mg and 100 mg) should not be substituted for Lynparza capsules (50 mg) on a milligram-to-milligram basis due to differences in the dosing and bioavailability of each formulation. Therefore, the specific dose recommendations for each formulation should be followed.

 * Tablet and capsule sizes not representative.

Lynparza should be started within 8 weeks after completion of a patient's final dose of the platinum containing regimen

For full prescribing information please refer here.